Steris PLC (NYSE:STE) reached a new 52-week high during trading on Monday . The company traded as high as $129.87 and last traded at $128.82, with a volume of 7271 shares. The stock had previously closed at $128.66.
A number of research firms have commented on STE. Zacks Investment Research cut shares of Steris from a “hold” rating to a “sell” rating in a report on Thursday. Stephens restated a “buy” rating and issued a $135.00 price target on shares of Steris in a report on Thursday, February 14th. Finally, JMP Securities restated a “buy” rating and issued a $135.00 price target on shares of Steris in a report on Thursday, February 14th. One equities research analyst has rated the stock with a sell rating and four have assigned a buy rating to the stock. Steris presently has an average rating of “Buy” and a consensus target price of $138.20.
The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.99 and a current ratio of 2.56. The firm has a market capitalization of $10.88 billion, a P/E ratio of 31.01 and a beta of 1.08.
Steris (NYSE:STE) last released its quarterly earnings data on Monday, February 11th. The medical equipment provider reported $1.26 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.26. Steris had a net margin of 9.85% and a return on equity of 12.50%. The firm had revenue of $696.24 million for the quarter, compared to analyst estimates of $687.90 million. Equities research analysts forecast that Steris PLC will post 4.79 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 21st. Shareholders of record on Wednesday, February 27th were paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.06%. The ex-dividend date was Tuesday, February 26th. Steris’s dividend payout ratio (DPR) is 32.77%.
In other Steris news, VP John Adam Zangerle sold 3,000 shares of the firm’s stock in a transaction on Friday, January 25th. The shares were sold at an average price of $115.00, for a total value of $345,000.00. Following the transaction, the vice president now directly owns 33,796 shares of the company’s stock, valued at $3,886,540. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Walter M. Rosebrough, Jr. sold 50,000 shares of the firm’s stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $125.00, for a total transaction of $6,250,000.00. Following the completion of the transaction, the chief executive officer now directly owns 98,895 shares in the company, valued at $12,361,875. The disclosure for this sale can be found here. Insiders sold 58,646 shares of company stock worth $7,284,093 over the last ninety days. Insiders own 2.38% of the company’s stock.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Retirement Systems of Alabama lifted its position in shares of Steris by 0.5% during the first quarter. Retirement Systems of Alabama now owns 110,110 shares of the medical equipment provider’s stock valued at $14,097,000 after purchasing an additional 550 shares in the last quarter. Louisiana State Employees Retirement System lifted its position in shares of Steris by 1.3% during the first quarter. Louisiana State Employees Retirement System now owns 22,700 shares of the medical equipment provider’s stock valued at $2,906,000 after purchasing an additional 300 shares in the last quarter. W.E. Donoghue & Co. LLC bought a new position in shares of Steris during the first quarter valued at about $1,067,000. First Manhattan Co. bought a new position in shares of Steris during the first quarter valued at about $330,000. Finally, First Citizens Bank & Trust Co. lifted its position in shares of Steris by 38.7% during the first quarter. First Citizens Bank & Trust Co. now owns 4,771 shares of the medical equipment provider’s stock valued at $611,000 after purchasing an additional 1,330 shares in the last quarter. 88.03% of the stock is currently owned by institutional investors.
Steris Company Profile (NYSE:STE)
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Story: How do candlesticks reflect price movement?
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.